361 related articles for article (PubMed ID: 3006077)
1. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
Mitsuya H; Broder S
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1911-5. PubMed ID: 3006077
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Broder S
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
[TBL] [Abstract][Full Text] [Related]
3. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
[TBL] [Abstract][Full Text] [Related]
4. Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Jarrett RF; Matsukura M; Di Marzo Veronese F; DeVico AL; Sarngadharan MG; Johns DG; Reitz MS; Broder S
Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2033-7. PubMed ID: 2436223
[TBL] [Abstract][Full Text] [Related]
5. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).
Balzarini J; Mitsuya H; De Clercq E; Broder S
Int J Cancer; 1986 Mar; 37(3):451-7. PubMed ID: 2419266
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.
Matsushita S; Mitsuya H; Reitz MS; Broder S
J Clin Invest; 1987 Aug; 80(2):394-400. PubMed ID: 3038956
[TBL] [Abstract][Full Text] [Related]
7. Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.
Hayashi S; Phadtare S; Zemlicka J; Matsukura M; Mitsuya H; Broder S
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6127-31. PubMed ID: 3261865
[TBL] [Abstract][Full Text] [Related]
8. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
Richman DD; Kornbluth RS; Carson DA
J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
[TBL] [Abstract][Full Text] [Related]
10. Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.
Mitsuya H; Matsushita S; Yarchoan R; Broder S
Princess Takamatsu Symp; 1984; 15():277-88. PubMed ID: 6085846
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of infectivity of HTLV-III in vitro.
Mitsuya H; Matsushita S; Harper ME; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4583s-4587s. PubMed ID: 2990689
[TBL] [Abstract][Full Text] [Related]
12. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.
Sodroski J; Goh WC; Rosen C; Tartar A; Portetelle D; Burny A; Haseltine W
Science; 1986 Mar; 231(4745):1549-53. PubMed ID: 3006244
[TBL] [Abstract][Full Text] [Related]
13. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.
Mitsuya H; Popovic M; Yarchoan R; Matsushita S; Gallo RC; Broder S
Science; 1984 Oct; 226(4671):172-4. PubMed ID: 6091268
[TBL] [Abstract][Full Text] [Related]
14. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
[TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of the acquired immunodeficiency syndrome.
Bowen DL; Lane HC; Fauci AS
Ann Intern Med; 1985 Nov; 103(5):704-9. PubMed ID: 2996403
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
[TBL] [Abstract][Full Text] [Related]
17. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK
Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934
[TBL] [Abstract][Full Text] [Related]
18. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
Nicholson JK; Cross GD; Callaway CS; McDougal JS
J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
[TBL] [Abstract][Full Text] [Related]
19. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
[TBL] [Abstract][Full Text] [Related]
20. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M
Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
